Industry Satellite Symposium Channel 3

Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC

Date
Thu, 25.03.2021
Time
12:50 - 14:20
Room
Channel 3
Chairs
  • M. Perol (Lyon, France)
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC Industry Satellite Symposium

Welcome and introduction

Lecture Time
12:50 - 12:55
Speakers
  • M. Perol (Lyon, France)
Session Name
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC
Room
Channel 3
Date
Thu, 25.03.2021
Time
12:50 - 14:20
Authors
  • M. Perol (Lyon, France)
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC Industry Satellite Symposium

Keeping up with the development in molecular testing for advanced NSCLC

Lecture Time
12:55 - 13:15
Speakers
  • K. Kerr (Aberdeen, United Kingdom)
Session Name
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC
Room
Channel 3
Date
Thu, 25.03.2021
Time
12:50 - 14:20
Authors
  • K. Kerr (Aberdeen, United Kingdom)
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC Industry Satellite Symposium

The patient with an EGFR Exon 20 insertion: Expert insights and recommendations

Lecture Time
13:15 - 13:35
Speakers
  • M. Perol (Lyon, France)
Session Name
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC
Room
Channel 3
Date
Thu, 25.03.2021
Time
12:50 - 14:20
Authors
  • M. Perol (Lyon, France)
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC Industry Satellite Symposium

Best practices in managing patients with De Novo ALK-Positive advanced NSCLC

Lecture Time
13:35 - 13:55
Speakers
  • R. Califano (Manchester, United Kingdom)
Session Name
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC
Room
Channel 3
Date
Thu, 25.03.2021
Time
12:50 - 14:20
Authors
  • R. Califano (Manchester, United Kingdom)
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC Industry Satellite Symposium

Panel discussion & live Q&A

Lecture Time
13:55 - 14:15
Speakers
  • A. Speakers (, Switzerland)
Session Name
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC
Room
Channel 3
Date
Thu, 25.03.2021
Time
12:50 - 14:20
Authors
  • A. Speakers (, Switzerland)
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC Industry Satellite Symposium

Concluding remarks

Lecture Time
14:15 - 14:20
Speakers
  • M. Perol (Lyon, France)
Session Name
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC
Room
Channel 3
Date
Thu, 25.03.2021
Time
12:50 - 14:20
Authors
  • M. Perol (Lyon, France)